Please login to the form below

tropical diseases

This page shows the latest tropical diseases news and features for those working in and with pharma, biotech and healthcare.

Pfizer signs $425m flu vaccine deal with Germany’s BioNTech

number of diseases, including Zika and rabies. ... Last year, a research team from the University of Munich’s Department of Infectious Diseases and Tropical Medicine moved a rabies vaccine developed by CureVac into what it said was the

Latest news

The power of pharma businesses to drive social change

For example, we have a focus on, and commitment to, combatting neglected tropical diseases (NTDs). ... Our research teams are collaborating with peers from organisations around the world to help in the development of effective treatments for diseases
Novartis' Swiss head of operations reveals job cuts

and said it planned to move its tropical diseases research from Singapore to California.
Sanofi pays $245m for FDA priority review voucher

Gilead Sciences bought one from Canada's Knight Therapeutics last year that was awarded by the FDA in return for developing a drug for a neglected tropical disease. ... The rising price also reflects the scarcity of the vouchers, which so far are only
GSK tops pharma access to medicines table

drive to tackle neglected tropical diseases," commented ATMI founder and chief executive Wim Leereveld. ... the pipeline tackling diseases affecting developing countries to 327 at last count.
Novartis licenses tuberculosis R&D to TB Alliance

As part of the deal the TB Alliance will assume financial and operational responsibility for the continued research into potential TB treatments discovered at the Novartis Institutes for Tropical Diseases (NITD).

More from news
Approximately 4 fully matching, plus 33 partially matching documents found.

Latest Intelligence

Reaching new heights

The seemingly intractable problems of neglected tropical diseases, compounded by poverty and war in Africa, finally appear to be responding to philanthropy-funded research and engagement, resulting in fundamental changes by ... biologics. Patients will
Pharma deals in August 2015

$65m. Antisense oligonucleotides target RNA and the new collaboration will extend into renal diseases, cardiovascular and metabolic fields. ... Introduced by the FDA in 2007, a priority review voucher (PRV) is an incentive for companies to invest in
Pharma deals during November 2014

Introduced by the FDA in 2007, a PRV is an incentive for companies to invest in treatments for neglected tropical diseases. ... One of 16 tropical diseases that qualify is leishmaniasis, for which Knight's Impavido (miltefosine) was approved in March by
Interview: Charles Mgone, EDCTP

We will ask them what areas they are interested in regarding our scope in HIV, TB, malaria and now neglected tropical diseases.”. ... EDCTP offers a more cost-effective and unified means of tackling poverty-related diseases.”.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

GSK's Ellen Strahlman joins med tech firm BD

global head of neglected tropical diseases.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Healthcare PR Senior Account Manager: Salary TBC

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior Account Manager – Healthcare Advertising: Salary TBC

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Writer, Healthcare Advertising, London: Excellent package

Senior Medical Writer, MedComms Agency: Salary TBC

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Sudler London - Senior Medical Writer: Competitive

Account Director, Healthcare Advertising Agency: Salary TBC

Senior Training Manager - Surrey: Competitive Salary &Bonus

Senior Medical Writer: Salary is DOE

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Graduate Scientific Editor: DOE

Associate Scientific Director: Salary TBC

Market Access Consultant - Greater Manchester: Negotiable

Account Manager: Negotiable

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Sudler London - Account Director: Competitive

Systematic Review Lead- London: Negotiable

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Subscribe to our email news alerts

PMHub

Add my company

Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....